The University of Chicago Header Logo

Connection

Tong-Chuan He to Bone Neoplasms

Back to Details
This is a "connection" page, showing publications Tong-Chuan He has written about Bone Neoplasms.
Tong-Chuan He
Connection Strength
2.468
Bone Neoplasms
  1. Lysophosphatidic acid acyltransferase ß (LPAATß) promotes the tumor growth of human osteosarcoma. PLoS One. 2010 Dec 01; 5(12):e14182.
    View in: PubMed
    Score: 0.304
  2. Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res. 2008 Sep; 466(9):2114-30.
    View in: PubMed
    Score: 0.256
  3. Osteosarcoma and osteoblastic differentiation: a new perspective on oncogenesis. Clin Orthop Relat Res. 2007 Jan; 454:237-46.
    View in: PubMed
    Score: 0.231
  4. Increased expression of S100A6 is associated with decreased metastasis and inhibition of cell migration and anchorage independent growth in human osteosarcoma. Cancer Lett. 2005 Nov 08; 229(1):135-48.
    View in: PubMed
    Score: 0.214
  5. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin Exp Metastasis. 2005; 22(4):319-29.
    View in: PubMed
    Score: 0.201
  6. Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer. 2002 Dec 01; 102(4):338-42.
    View in: PubMed
    Score: 0.174
  7. Integrative analysis of immune-related multi-omics profiles identifies distinct prognosis and tumor microenvironment patterns in osteosarcoma. Mol Oncol. 2022 06; 16(11):2174-2194.
    View in: PubMed
    Score: 0.164
  8. SP1-induced long non-coding RNA SNHG6 facilitates the carcinogenesis of chondrosarcoma through inhibiting KLF6 by recruiting EZH2. Cell Death Dis. 2021 01 11; 12(1):59.
    View in: PubMed
    Score: 0.153
  9. [Twist regulates proliferation, migration and invasion of osteosarcoma cells in vitro]. Nan Fang Yi Ke Da Xue Xue Bao. 2018 May 20; 38(5):554-560.
    View in: PubMed
    Score: 0.127
  10. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways. Curr Cancer Drug Targets. 2015; 15(8):726-38.
    View in: PubMed
    Score: 0.101
  11. Exomic analysis of myxoid liposarcomas, synovial sarcomas, and osteosarcomas. Genes Chromosomes Cancer. 2014 Jan; 53(1):15-24.
    View in: PubMed
    Score: 0.093
  12. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/ß-catenin signaling. Oncol Rep. 2013 Oct; 30(4):1723-30.
    View in: PubMed
    Score: 0.091
  13. IGFBP5 domains exert distinct inhibitory effects on the tumorigenicity and metastasis of human osteosarcoma. Cancer Lett. 2013 Aug 09; 336(1):222-30.
    View in: PubMed
    Score: 0.090
  14. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma. Clin Cancer Res. 2010 Apr 15; 16(8):2235-45.
    View in: PubMed
    Score: 0.073
  15. Establishment and characterization of a new highly metastatic human osteosarcoma cell line. Clin Exp Metastasis. 2009; 26(7):599-610.
    View in: PubMed
    Score: 0.068
  16. S100A6 expression and function in human osteosarcoma. Clin Orthop Relat Res. 2008 Sep; 466(9):2060-70.
    View in: PubMed
    Score: 0.064
  17. LncRNA SNHG3 regulates the BMSC osteogenic differentiation in bone metastasis of breast cancer by modulating the miR-1273g-3p/BMP3 axis. Biochem Biophys Res Commun. 2022 02 26; 594:117-123.
    View in: PubMed
    Score: 0.041
  18. BMP9 inhibits the bone metastasis of breast cancer cells by downregulating CCN2 (connective tissue growth factor, CTGF) expression. Mol Biol Rep. 2014 Mar; 41(3):1373-83.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.